Ilya M. Nasrallah

Ilya M. Nasrallah

Auto-generated profile, based on publicly available information

Ilya M. Nasrallah

Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2020 in Radiology
Verified
Journal Article
Closed access
ARAndreas M. Rauschecker
Andreas M. Rauschecker
JRJeffrey D. Rudie
Jeffrey D. Rudie
LXLong Xie
Long Xie
JWJiancong Wang
Jiancong Wang
MDMichael Tran Duong
Michael Tran Duong
JGJames C. Gee
James C. Gee
An artificial intelligence system extracted meaningful image features and calculated disease probabilities to derive brain MRI differential diagnoses approaching neuroradiologists’ accuracy for 19 ... Background Although artificial intelligence (AI) shows promise across many aspects of radiology, the use of AI to create differential diagnoses for rare and common diseases at brain MRI has not bee...

1 October 2020 in Science
Verified
Journal Article
Closed access
PDF file
NDNabil F. Darwich
Nabil F. Darwich
JPJessica M. Phan
Jessica M. Phan
BKBoram Kim
Boram Kim
ESEunRan Suh
EunRan Suh
JPJohn D. Papatriantafyllou
John D. Papatriantafyllou
ELEdward B. Lee
Edward B. Lee
Two ways to get tangled?: Neurodegeneration in Alzheimer's disease dementia is associated with neurofibrillary tangles composed of aggregated tau protein. Darwich et al. describe an additional form of autosomal-dominant dementia with neurofibrillary tangles linked to a hypomorph mutation in valosin-containing protein (VCP). VCP was found to disaggregate pathologic tau, and the hypomorph mutation increased tau accumulation in cells and mice. These findings highlight the role of protein turnover in maintaining neuronal health and suggest that VCP may provide a therapeutic target for Alzheimer's disease. Science , this issue p. eaay8826

15 August 2024 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
ZYZhijian Yang
Zhijian Yang
JWJunhao Wen
Junhao Wen
GEGuray Erus
Guray Erus
SGSindhuja T. Govindarajan
Sindhuja T. Govindarajan
RMRanda Melhem
Randa Melhem
CDChristos Davatzikos
Christos Davatzikos

1 May 2021 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
INIlya M. Nasrallah
Ilya M. Nasrallah
SGSarah A. Gaussoin
Sarah A. Gaussoin
RPRaymond Pomponio
Raymond Pomponio
SDSudipto Dolui
Sudipto Dolui
GEGuray Erus
Guray Erus
PZPerla Zarate-Abbott
Perla Zarate-Abbott
Magnetic resonance imaging (MRI) data from the Systolic Blood Pressure Intervention Trial (SPRINT), the Action to Control Cardiovascular Risk in Diabetes (ACCORD) blood pressure trial, and the Intensive vs Standard Ambulatory Blood Pressure Lowering to Prevent Functional Decline in the Elderly (INFINITY) trial have all indicated less progression of white matter lesions (WML or leukoaraiosis), a biomarker for cerebrovascular injury, with more intensive blood pressure control.1-3 However, the effect of intensive treatment on other mechanistic markers of cognitive impairment and dementia has yet to be explored. The most common cause of dementia in older adults is Alzheimer disease (AD).4 Vascular disease is a very common comorbidity and may play a factor in initiating or accelerating AD neuropathology.5,6 Some studies have found that treating hypertension may reduce the incidence of AD7; however, it is unclear whether this could be a direct effect on AD-related neurodegeneration or comorbid vascular pathology. The neurodegeneration of AD results in brain atrophy, favoring but not limited to particular brain regions, and biomarkers measuring these changes may be more sensitive to early AD-related change than downstream cognitive or clinical variables, such as incident dementia.8 Both ACCORD and SPRINT showed small but statistically significant decreases in total brain volume (TBV) with intensive treatment compared with standard treatment,1,9 although it is unclear to what extent these differences reflect atrophy vs factors such as hydration status.10

8 January 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZYZhijian Yang
Zhijian Yang
JWJunhao Wen
Junhao Wen
AAAhmed Abdulkadir
Ahmed Abdulkadir
YCYuhan Cui
Yuhan Cui
GEGuray Erus
Guray Erus
CDChristos Davatzikos
Christos Davatzikos
Disease heterogeneity has been a critical challenge for precision diagnosis and treatment, especially in neurologic and neuropsychiatric diseases. Many diseases can display multiple distinct brain phenotypes across individuals, potentially reflecting disease subtypes that can be captured using MRI and machine learning methods. However, biological interpretability and treatment relevance are limited if the derived subtypes are not associated with genetic drivers or susceptibility factors. Herein, we describe Gene-SGAN – a multi-view, weakly-supervised deep clustering method – which dissects disease heterogeneity by jointly considering phenotypic and genetic data, thereby conferring genetic correlations to the disease subtypes and associated endophenotypic signatures. We first validate the generalizability, interpretability, and robustness of Gene-SGAN in semi-synthetic experiments. We then demonstrate its application to real multi-site datasets from 28,858 individuals, deriving subtypes of Alzheimer’s disease and brain endophenotypes associated with hypertension, from MRI and single nucleotide polymorphism data. Derived brain phenotypes displayed significant differences in neuroanatomical patterns, genetic determinants, biological and clinical biomarkers, indicating potentially distinct underlying neuropathologic processes, genetic drivers, and susceptibility factors. Overall, Gene-SGAN is broadly applicable to disease subtyping and endophenotype discovery, and is herein tested on disease-related, genetically-associated neuroimaging phenotypes.

24 October 2022 in Journal of Digital Imaging
Verified
Journal Article
Closed access
PDF file
CSChintan Shah
Chintan Shah
KDKarapet Davtyan
Karapet Davtyan
INIlya Nasrallah
Ilya Nasrallah
RBR Nick Bryan
R Nick Bryan
SMSuyash Mohan
Suyash Mohan